|
🐜
|
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
153 auth.
K. Shitara,
M. Özgüroğlu,
Y. Bang,
M. Di Bartolomeo,
M. Mandalà,
M. Ryu,
L. Fornaro,
T. Olesiński,
C. Caglevic,
H. Chung,
K. Muro,
E. Goekkurt,
W. Mansoor,
R. McDermott,
E. Shacham-Shmueli,
...
Xinqun Chen,
C. Mayo,
S. Kang,
A. Ohtsu,
C. Fuchs,
G. Lerzo,
J. O'Connor,
G. Mendez,
J. Lynam,
N. Tebbutt,
M. Wong,
A. Strickland,
C. Karapetis,
D. Goldstein,
P. Vasey,
J. Van Laethem,
E. Van Cutsem,
S. Berry,
M. Vincent,
Bettina Muller,
F. Rey,
A. Zambrano,
J. Guerra,
M. Krogh,
L. Baeksgaard,
M. Yilmaz,
A. Elme,
Andrus Magi,
P. Auvinen,
T. Alanko,
M. Moehler,
V. Kunzmann,
T. Seufferlein,
P. Thuss-Patience,
T. Hoehler,
G. Haag,
S. Al-Batran,
H. Castro,
K. Lopez,
Mynor Aguilar Vasquez,
Mario Sandoval,
K. Lam,
S. Cuffe,
C. Kelly,
R. Geva,
A. Hubert,
A. Beny,
B. Brenner,
Aprile Giuseppe,
A. Falcone,
E. Maiello,
R. Passalacqua,
V. Montesarchio,
H. Hara,
K. Chin,
T. Nishina,
Y. Komatsu,
N. Machida,
S. Hironaka,
T. Satoh,
T. Tamura,
Naotaoshi Sugimoto,
Haruhiko Cho,
Yashushi Omuro,
Ken Kato,
M. Goto,
I. Hyodo,
Kazuhiro Yoshida,
H. Baba,
T. Esaki,
J. Furuse,
Wan Zamaniah Wan Mohammed,
Carlos Hernandez Hernandez,
Juan Casas Garcia,
Adriana Dominguez Andrade,
Katriona Clarke,
G. Hjortland,
N. Glenjen,
T. Kubiatowski,
J. Jacek,
M. Wojtukiewicz,
S. Lazarev,
Yuri Lancukhay,
Sergey Afanasayev,
V. Moiseyenko,
V. Kostorov,
S. Protsenko,
V. Shirinkin,
D. Sakaeva,
N. Fadeeva,
W. Yong,
C. Ng,
B. Robertson,
B. Rapaport,
G. Cohen,
L. Dreosti,
P. Ruff,
C. Jacobs,
G. Landers,
W. Szpak,
S. Roh,
Jeeyun Lee,
Yeul-Hong Kim,
H. Chung,
Maria Alsina Maqueda,
F. Longo Muñoz,
Andres Cervantes Aguilar,
Enrique Aranda Aguilar,
P. García Alfonso,
F. Rivera,
Jaime Feliu Batle,
R. Pazo Cid,
K. Yeh,
Jen‐Shi Chen,
Y. Chao,
C. Yen,
O. Kara,
Ş. Yalçın,
D. Hochhauser,
I. Chau,
A. Benson,
V. Shankaran,
W. Shaib,
P. Philip,
V. Sharma,
R. Siegel,
Weijing Sun,
Z. Wainberg,
B. George,
A. Bullock,
S. Myrick,
Josephine Faruol,
Richard Siegel,
T. Larson,
C. Becerra,
Suresh Ratnam,
D. Richards,
Stephen L. Riche
|
9 |
2018 |
9
🐜
|
|
🐜
|
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
223 auth.
T. Powles,
P. Tomczak,
S. Park,
B. Venugopal,
T. Ferguson,
S. Symeonides,
J. Hajek,
H. Gurney,
Yen‐Hwa Chang,
Jae Lyun Lee,
N. Sarwar,
A. Thiery-Vuillemin,
M. Gross-Goupil,
M. Mahave,
N. Haas,
...
P. Sawrycki,
J. Burgents,
Lei Xu,
K. Imai,
D. Quinn,
T. Choueiri,
T. Choueiri,
Thomas Ferguson,
Tzu-Ping Lin,
S. Symeonides,
N. Haas,
H. Gurney,
C. Chevreau,
J. Burke,
G. Doshi,
B. Melichar,
D. Topart,
S. Oudard,
Evgeniy Kopyltsov,
H. Hammers,
D. Quinn,
A. Alva,
J. Menezes,
A. G. Silva,
E. Winquist,
A. Hamzaj,
G. Procopio,
B. Karaszewska,
E. Nowakowska-Zajdel,
B. Alekseev,
R. Gafanov,
A. Izmailov,
A. Semenov,
S. Afanasyev,
O. Lipatov,
T. Powles,
S. Srinivas,
D. McDermott,
S. T. Kochuparambil,
I. Davis,
K. Peltola,
R. Sabbatini,
Jinsoo Chung,
M. Shkolnik,
V. Matveev,
P. Gajate Borau,
S. McCune,
Thomas E. Hutson,
A. Dri,
Silvio Correia Sales,
Carrie Yeung,
Carmen Marcela Alcala Castro,
P. Bostrom,
B. Laguerre,
C. Buttigliero,
U. de Giorgi,
E. Fomin,
Y. Zakharia,
C. Hwang,
E. Singer,
J. Yorio,
D. Waterhouse,
R. Kowalyszyn,
M. Alfie,
E. Y. Yanez Ruiz,
T. Buchler,
Krista Kankaanranta,
G. Ferretti,
G. Kimura,
K. Nishimura,
N. Masumori,
S. Tamada,
H. Kato,
H. Kitamura,
I. Danielewicz,
J. Wójcik-Tomaszewska,
N. Sala González,
K. Chiu,
M. Atkins,
E. Heath,
G. Rojas-Uribe,
M. González Fernández,
S. Feyerabend,
S. Pignata,
K. Numakura,
Bozena Cybulska Stopa,
R. Zukov,
M. A. Climent Duran,
P. Maroto Rey,
A. Montesa Pino,
Chao‐Hsiang Chang,
Salil Vengalil,
T. Waddell,
P. Cobb,
R. Hauke,
Daniel M. Anderson,
J. Sarantopoulos,
T. Gourdin,
Tian Zhang,
G. Jayram,
L. Fein,
C. Harris,
P.M.M. Beato,
F. Flores,
Á. Estay,
J. Rubiano,
J. Bedke,
S. Hauser,
A. Neisius,
J. Busch,
S. Anai,
H. Tsunemori,
Dariusz Sawka,
Bożena Sikora-Kupis,
J. Arranz,
I. Delgado,
C.-H. Chen,
E. Gunderson,
S. Tykodi,
A. Koletsky,
Kevin Chen,
M. Agrawal,
D. Kaen,
J. P. Sade,
M. Tatangelo,
F. Parnis,
Fernando Maciel Barbosa,
G. Faucher,
N. Iqbal,
D. Marceau,
Jean-Benoît Paradis,
N. Hanna,
Alejandro Acevedo,
C. Ibáñez,
L. Villanueva,
Pedro Pablo Galaz,
I. Durango,
R. Manneh,
Z. Král,
P. Holečková,
H. Hakkarainen,
H. Ronkainen,
S. Abadie-Lacourtoisie,
S. Tartas,
P. Goebell,
M. Grimm,
T. Hoefner,
M. Wirth,
A. Panic,
W. Schultze‐Seemann,
A. Yokomizo,
R. Mizuno,
H. Uemura,
M. Eto,
M. Tsujihata,
Y. Matsukawa,
Y. Murakami,
Miso Kim,
P. Hamberg,
Malgorzata Marczewska-Skrodzka,
C. Szczylik,
A. Humphreys,
Peter Jiang,
Birendra Kumar,
G. Lu,
A. Desai,
J. Karam,
G. Keogh,
M. Fleming,
J. Zarbá,
Viviana E. Leiva,
G. Mendez,
Samuel J. Harris,
Stephen J. Brown,
Joao Neif Antonio Junior,
Rita de Cassia Costamilan,
R. O. Rocha,
D. Muniz,
L. Brust,
Aly-Khan A. Lalani,
J. Graham,
M. Levesque,
F. Orlandi,
R. Kotásek,
J. Deville,
D. Borchiellini,
A. Merseburger,
M. Rink,
F. Roos,
Raymond J. McDermott,
M. Oyama,
Yoshiaki Yamamoto,
Y. Tomita,
Yuji Miura,
N. Ioritani,
Hans Westgeest,
T. Kubiatowski,
W. Bal,
R. Gironés Sarrió,
Juliet M. Rowe,
D. Prow,
F. Senecal,
N. Hashemi-Sadraei,
S. Cole,
S. Kendall,
D. Richards,
I. Schnadig,
M. Gupta
|
7 |
2022 |
7
🐜
|
|
🦁
|
Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas.
9 auth.
T. Kubiatowski,
T. Jang,
M. Lachyankar,
R. Salmonsen,
R. Nabi,
P. Quesenberry,
...
N. Litofsky,
A. Ross,
L. Recht
|
6 |
2001 |
6
🦁
|
|
🐜
|
Risk factors for brain relapse in HER2-positive metastatic breast cancer patients
10 auth.
R. Duchnowska,
R. Dziadziuszko,
B. Czartoryska-Arłukowicz,
B. Radecka,
B. Szostakiewicz,
K. Sosińska-Mielcarek,
...
A. Karpińska,
E. Starosławska,
T. Kubiatowski,
C. Szczylik
|
5 |
2009 |
5
🐜
|
|
🐜
|
Life quality of women with breast cancer after mastectomy or breast conserving therapy treated with adjuvant chemotherapy.
8 auth.
Marzena Kamińska,
T. Ciszewski,
B. Kukiełka-Budny,
T. Kubiatowski,
Bożena Baczewska,
M. Makara-Studzińska,
...
E. Starosławska,
I. Bojar
|
5 |
2015 |
5
🐜
|
|
🐜
|
Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy.
7 auth.
Marzena Kamińska,
T. Kubiatowski,
T. Ciszewski,
Krzysztof J Czarnocki,
M. Makara-Studzińska,
I. Bojar,
...
E. Starosławska
|
5 |
2015 |
5
🐜
|
|
🐜
|
BRAF and MEK inhibitors rechallenge as effective treatment for patients with metastatic melanoma
14 auth.
B. Cybulska-Stopa,
P. Rogala,
A. Czarnecka,
Łukasz Galus,
R. Dziura,
M. Rajczykowski,
T. Kubiatowski,
M. Wiśniewska,
Adrianna Gęga-Czarnota,
P. Teterycz,
...
M. Ziobro,
R. Suwiński,
J. Mackiewicz,
P. Rutkowski
|
3 |
2020 |
3
🐜
|
|
🐜
|
Tissue MicroRNA Expression as a Predictor of Response to Immunotherapy in NSCLC Patients
26 auth.
A. Grenda,
P. Krawczyk,
J. Błach,
I. Chmielewska,
T. Kubiatowski,
S. Kieszko,
K. Wojas-Krawczyk,
Tomasz Kucharczyk,
B. Jarosz,
I. Paśnik,
Małgorzata Borowiec-Bar,
M. Frąk,
R. Kieszko,
M. Szczyrek,
K. Reszka,
...
K. Krukowska,
A. Kolak,
S. Mańdziuk,
D. Kowalski,
M. Sawicki,
D. Świniuch,
E. Starosławska,
R. Ramlau,
J. Szumiło,
M. Krzakowski,
J. Milanowski
|
3 |
2021 |
3
🐜
|
|
🐢
|
Imperfect Predictors for Lung Cancer Immunotherapy—A Field for Further Research
K. Wojas-Krawczyk,
T. Kubiatowski
|
3 |
2020 |
3
🐢
|
|
🐜
|
[Decreased osteonectin and fibronectin gene expression in endometrial cancer cancer as a prognostic marker].
7 auth.
K. Futyma,
T. Kubiatowski,
K. Różyńska,
M. Zdunek,
J. Kotarski,
T. Rechberger,
...
J. Wojcierowski
|
3 |
2009 |
3
🐜
|
